If you have had the ChondroFiller injection, one of the most natural questions is how you — and your clinician — will know whether it is making a real difference. Pain improvement matters, but assessment goes further than that. This article sets out the practical ways clinicians monitor progress after the ChondroFiller injection, and what to expect from the evaluation process.

Symptoms and Joint Function Come First

The most important measures remain how you feel and how the joint works: less pain, easier movement and better day-to-day function. Clinicians ask carefully about your symptoms and activities because real-world comfort and mobility are what matter most after a joint-preserving injection. Meaningful improvement in these areas is itself strong evidence that the treatment is helping.

Patient-Reported Outcome Scores

Standardised scores give a clear, repeatable way to compare how you are doing before and after treatment. For knee patients, the International Knee Documentation Committee (IKDC) score is widely used; published clinical data for ChondroFiller show mean IKDC improvements of approximately 30 points over 12 to 36 months — consistently above the minimal clinically important difference threshold of around 16 points. For hip patients, the modified Harris Hip Score (mHHS) is commonly applied, with published series reporting improvements of more than 30 points. Responses vary between individuals, and no outcome can be guaranteed; these figures reflect what has been observed in clinical studies of the device.

A 2023 study of ChondroFiller in thumb-base (trapeziometacarpal) osteoarthritis also reported improvements in pain and grip strength at 24 months, illustrating that the evaluation approach extends to smaller joints (Corain et al., 2023). The right scoring tool is chosen to match the joint and the patient's activities.

Imaging: MRI and MOCART

Magnetic resonance imaging (MRI) is a painless way to look at the joint and surrounding tissues over time. A validated MRI scoring system called MOCART (Magnetic Resonance Observation of Cartilage Repair Tissue) assesses how well the repair tissue has filled the defect and integrated with the surrounding cartilage. In published ChondroFiller studies, MOCART scores have ranged from approximately 70 to 87, indicating good-quality structural repair and substantial defect filling. Imaging complements the picture built from symptoms and scores; it is one part of the assessment rather than a standalone verdict.

Regular Follow-Up Appointments

Structured follow-up allows your clinician to review progress at agreed intervals, answer questions and adjust advice on activity levels or physiotherapy. At the London Cartilage Clinic, Professor Paul Lee takes a thorough, patient-focused approach that combines clinical examination, patient-reported scores and imaging review. Each appointment is an opportunity to build a fuller picture of how the injection is performing for you specifically.

Keeping Expectations Realistic

ChondroFiller is a Class III CE-marked collagen scaffold device — not a cure for arthritis and not a guarantee of cartilage regrowth. The aim is to support joint preservation and ease symptoms by providing a matrix that encourages the body's own progenitor cells to regenerate cartilage tissue over time. Published evidence suggests meaningful functional gains in many patients, but how much benefit occurs, and how long it lasts, varies from person to person.

Conclusion

Judging whether the ChondroFiller injection is helping involves combining symptom and function review, validated patient-reported scores, imaging such as MRI and MOCART assessment, and regular clinical follow-up. At the London Cartilage Clinic, this multi-faceted approach underpins every evaluation. If you would like to discuss whether ChondroFiller is appropriate for you, or to review your progress, a consultation with Professor Paul Lee can be arranged.

References

Corain, M., Zanotti, F., Giardini, M., Gasperotti, L., Invernizzi, E., Biasi, V., & Lavagnolo, U. (2023). The use of an acellular collagen matrix ChondroFiller Liquid for trapeziometacarpal osteoarthritis. Cartilage.